Urtė Šachlevičiūtė

Urtė Šachlevičiūtė

Auto-generated profile, based on publicly available information

Urtė Šachlevičiūtė

Institute of Synthetic Chemistry Kaunas University of Technology Kaunas Lithuania

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2023 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
UŠUrtė Šachlevičiūtė
Urtė Šachlevičiūtė
NKNeringa Kleiziene
Neringa Kleiziene
ABAurimas Bieliauskas
Aurimas Bieliauskas
AŠAlgirdas Šačkus
Algirdas Šačkus
TOTill Opatz
Till Opatz
A synthesis of pyrrolo[2,1-a]isoquinolines based on intramolecular condensation of an enaminone intermediate obtained by C-acylation of an N-alkylated 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinolinium salt was developed.

5 October 2023 in Archiv der Pharmazie
Verified
Journal Article
Open access
UŠUrtė Šachlevičiūtė
Urtė Šachlevičiūtė
GGGabriel Gonzalez
Gabriel Gonzalez
MKMarie Kvasnicová
Marie Kvasnicová
ŠŠŠárka Štěpánková
Šárka Štěpánková
NKNeringa Kleiziene
Neringa Kleiziene
AŽAsta Žukauskaitė
Asta Žukauskaitė
A library of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives was prepared from N‐Boc‐3‐azetidinone employing the Horner‐Wadsworth‐Emmons reaction, rhodium(I)‐catalyzed conjugate addition of arylboronic acids, and subsequent elaborations to obtain N‐unprotected hydrochlorides, N‐alkylated and N‐acylated azetidine derivatives. The compounds were evaluated for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, revealing several derivatives to possess AChE inhibition comparable to that of the AChE inhibitor rivastigmine. The binding mode of the AChE inhibitor donepezil and selected active compounds 26 and 27 within the active site of AChE was studied using molecular docking. Furthermore, the neuroprotective activity of the prepared compounds was evaluated in models associated with Parkinson's disease (salsolinol‐induced) and aspects of Alzheimer's disease (glutamate‐induced oxidative damage). Compound 28 showed the highest neuroprotective effect in both salsolinol‐ and glutamate‐induced neurodegeneration models, and its protective effect in the glutamate model was revealed to be driven by a reduction in oxidative stress and caspase‐3/7 activity.

12 July 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
GMGita Matulevičiūtė
Gita Matulevičiūtė
NKNeringa Kleiziene
Neringa Kleiziene
GRGreta Račkauskienė
Greta Račkauskienė
VMVytas Martynaitis
Vytas Martynaitis
ABAurimas Bieliauskas
Aurimas Bieliauskas
AŠAlgirdas Šačkus
Algirdas Šačkus
In this study, we prepared a series of new N -(aminocycloalkylene)amino acid derivatives for use in chiral building blocks.